|
 Help
 Merz - our research for your health. However, due to the already elevated calcium concentration, the signal can no longer be detected (occurrence of dementia symptoms).
Help: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Help is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Help now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Help very serious, so that we can offer you the best drug for each treatment and therapy you need. Help and Merz means research for your health. High-quality products and information about Help can be found on our website. Visit us online and learn everything about Help from one of Germany's leading health care companies. Our contribution to Help: read here what we can do for you. Further links: Axura: Information for professionals.>>
Help and Merz means research for your health.
Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . Under physiological conditions, the NMDA receptor is blocked by magnesium ions, thereby protecting the neuron against glutamatergic excitotoxicity. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . In the course of the disease, the chronic release of glutamate and the permanently increased intracellular calcium concentration leads to neuronal degeneration (neurodegeneration). The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . During physiological learning and memory processes, high concentrations of synaptic glutamate are transiently released. The pathological, sustained release of low glutamate concentrations, from both neurones and surrounding glia cells, also displaces magnesium from the NMDA receptor channel. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . About 70 percent of all excitatory synapses in the central nervous system are stimulated by the neurotransmitter glutamate. Glutamate is the principal neurotransmitter in the brain. vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . Gedächtnis , Demenz . Merz , Multi Infarct Dementia . Dysfunction of glutamatergic neurotransmission is involved in pathomechanism of neurodegenerative dementia. Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . Dysfunction of glutamatergic neurotransmission is involved in pathomechanism of neurodegenerative dementia. Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. The safety of the combination therapy was investigated in a postmarketing surveillance study. Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . If you have questions regarding Memantine, Axura or Namenda, please contact the responsible department. A significant improvement in cognitive performance is seen during treatment with the NMDA antagonist, especially when only small vessels are affected. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . About 70 percent of all excitatory synapses in the central nervous system are stimulated by the neurotransmitter glutamate. Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . Alzheimer's Symptoms , Mental Confusion . During learning and memory processes (i e transient high glutamate release), memantine - the fast, voltage-dependent NMDA-receptor antagonist - leaves the NMDA receptor for a short time. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . In the case of learning and memory processes, the transient synaptic release of glutamate causes more calcium to flow into the cell. Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's .
 Help
|
